PEPG (STOCKS)
PepGen Inc. Common Stock
$1.500000
+0.030000 (+2.04%)
Prev close: $1.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James Gregg McArthur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $106.17M
- Employees
- 62
- P/E (TTM)
- -0.87
- P/B (TTM)
- 0.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
4
Buy
1
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.26 | $-0.32 | +0.0582 | +18.29% |
|
Dec 2025 (Q4)
|
$-0.27 | $-0.38 | +0.1118 | +29.28% |
|
Sep 2025 (Q3)
|
$-0.52 | $-0.58 | +0.0563 | +9.77% |
|
Jun 2025 (Q2)
|
$-0.70 | $-0.84 | +0.1441 | +17.07% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.08M |
| Operating Expenses | $81.23M |
| Research and Development | $58.67M |
| Other Operating Expenses | $22.56M |
| Operating Income/Loss | -$81.23M |
| Income/Loss From Continuing Operations After Tax | -$77.22M |
| Income/Loss From Continuing Operations Before Tax | -$77.15M |
| Income Tax Expense/Benefit | $64.00K |
| Net Income/Loss | -$77.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$77.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$77.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.46 |
| Diluted Earnings Per Share | -$1.46 |
| Basic Average Shares | 145,156,166 |
| Diluted Average Shares | 145,156,166 |
| Assets | $156.30M |
| Current Assets | $134.27M |
| Cash | $132.30M |
| Other Current Assets | $1.97M |
| Noncurrent Assets | $22.02M |
| Fixed Assets | $1.57M |
| Other Non-current Assets | $20.46M |
| Liabilities | $22.32M |
| Current Liabilities | $8.96M |
| Accounts Payable | $622.00K |
| Wages | $1.43M |
| Other Current Liabilities | $6.91M |
| Noncurrent Liabilities | $13.35M |
| Equity | $133.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $133.98M |
| Liabilities And Equity | $156.30M |
| Net Cash Flow From Operating Activities | -$77.13M |
| Net Cash Flow From Operating Activities, Continuing | -$77.13M |
| Net Cash Flow From Investing Activities | -$33.84M |
| Net Cash Flow From Investing Activities, Continuing | -$33.84M |
| Net Cash Flow From Financing Activities | $103.72M |
| Net Cash Flow From Financing Activities, Continuing | $103.72M |
| Net Cash Flow | -$7.26M |
| Net Cash Flow, Continuing | -$7.26M |
| Comprehensive Income/Loss | -$77.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$77.25M |
| Other Comprehensive Income/Loss | -$54.15M |